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JONATHAN TODRES, LAUREL R. HYLE AND ELIZABETH SEPPER*
I. Introduction
In 2006, a number of important international health law issues continued to attract
significant attention worldwide, including the threat of public health emergencies, HIV/
AIDS, intellectual property issues, biomedical science developments, bioterrorism, and
health and human rights concerns. At the same time, newly emerging public health con-
cerns, such as obesity, found their way on to the agendas of governments and international
organizations. These developments confirm the growing impact of public health issues in
the international arena. In turn, international and regional efforts to respond to public
health issues increased, reflecting recognition of the need for coordinated multilateral re-
sponses in this field.
II. Public Health Emergencies, Infectious Diseases, and Immunization
Programs
Infectious diseases and the threat of a global pandemic continue to concern public
health officials throughout the world. Avian influenza remains a risk, but it is not the only
disease that presents a threat.1 The 2005 revision of the International Health Regulations
* Jonathan Todres is an Acting Assistant Professor at New York University School of Law and Chair of
the International Health Law Committee of the ABA Section of International Law. Laurel R. Hyle is an
Associate Legal Officer at The University of Texas M. D. Anderson Cancer Center and a Vice Chair of the
International Health Law Committee. Elizabeth Sepper is an Institute for International Law and Justice
Scholar and LLM candidate in International Legal Studies at New York University School of Law. This
article covers events and developments that occurred from January 1, 2006, to December 1, 2006. As in prior
years, space limitations for this article do not allow for a discussion of all of the important developments in
the field of international health law. The omission of an area of international health law or a particular
development should not be construed as suggesting that such issue is not important.
1. See World Health Org., Epidemic and Pandemic Alert and Response (EPR), Avian Influenza-Situa-
tion in Indonesia-Update 37, Nov. 13, 2006, http://www.who.int/csr/don/2006-1 l-13/en/index.html (re-
porting two additional cases of human infection with the H5N1 avian influenza virus, bringing the total
number of confirmed cases in Indonesia to seventy-four, fifty-six of which have been fatal); World Health
Org., Epidemic and Pandemic Alert and Response (EPR), Disease Outbreaks by Year, http://www.who.int/
csr/don/archive/year/2006/en/index.html (last visited Nov. 26, 2006) (reporting on such disease outbreaks as
meningococcal disease in Sudan and suspected plague outbreak in the Democratic Republic of Congo).
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(HR)2 marked a milestone achievement in developing an effective response to public
health risks and emergencies.3 The revision significantly broadens the scope of the regu-
lations and requires countries to develop the capacity to detect, evaluate, and report cer-
tain public health events in a timely manner as well as respond promptly and effectively to
public health risks and emergencies. 4 As the IHR does not enter into force until June 15,
2007, several interim steps were taken in 2006, evidencing agreement that public health
preparedness must be accelerated to avert a devastating pandemic from avian influenza or
any other disease.
In May 2006, the World Health Assembly adopted a resolution calling for early compli-
ance by World Health Organization (WHO) Member States with the provisions of the
IHR relevant to the risk posed by avian influenza and a potential pandemic of human
influenza.5 Provisions relating to "surveillance, reporting, information-sharing, transport
of biological substances and public health measures for travelers were identified as impor-
tant to ensure a strong and coordinated response by the international community to both
the present situation and a possible pandemic." 6 Although early compliance is voluntary
under the resolution, its adoption reflects the consensus view that health issues must be a
top priority for all governments. In adopting the 2006 resolution, WHO Member States
affirmed that "[e]ffective and transparent communications are crucial for the early detec-
tion and notification of human cases of influenza, rapid risk assessment and the immediate
implementation of appropriate containment and response measures should a pandemic
strain emerge."7 The resolution also urges countries to collaborate to ensure adequate
vaccine supplies.8 Another interim step by the WHO was to appoint the WHO Influenza
Pandemic Task Force as the entity temporarily responsible for coordinating responses to
avian influenza outbreaks until the IHR enter into force.9
While avian influenza continues to garner most of the headlines related to public health
emergencies, other diseases continue to present challenges for populations around the
globe. Although great progress has been made in recent decades in combating infectious
diseases, millions of children do not receive immunizations for such basic diseases as mea-
sles, diphtheria, tetanus, and pertussis. lo An estimated three million people die each year
from vaccine-preventable diseases." In 2006, international organizations continued to
2. See Revision of the International Health Regulations, WHO Doc. A58/55 (May 23, 2005), available at
http://www.who.int/gb/ebwha/pdffiles/WHAS8/A58-55-en.pdf. [hereinafter IHR]. The fHR apply to all
192 WHO Member States.
3. For more on the IHR, see Jonathan Todres et al., International Health Law, 40 INr'L LAW. 453, 453-55
(2006).
4. See IHR, supra note 2, at arts. 5, 13.
5. See Application of the International Health Regulations (2005), WHO Doc. A59NVR/8 (May 26, 2006),
available at http'J/www.who.int/gb/ebwha/pdf filesWHA59/WHA59_2-en.pdf [hereinafter IHR Early
Compliance Resolution].
6. World Health Org., Epidemic and Pandemic Alert and Response (EPR), Summary Update on the IR
(2005), Sept. 2006, available at http-J/www.who.int/csr/ihr/en (follow "Summary Update on 1 HR (2005)").
7. Id.
8. See IHR Early Compliance Resolution, supra note 5, 4(5).
9. See id. 1 5(4).
10. David E. Bloom et al., The Value of Vaccination, 6 WORLD ECON. 15, 15 (July-Sept. 2005).
11. Id. at 16.
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work with governments to ensure greater commitment to immunization programs. 12 The
Global Immunization Vision and Strategy (GIVS) kicked off its first full year in 2006.
The program, launched by WHO and UNICEF in late 2005, aims to achieve a 90 percent
or greater national vaccination coverage in all countries and a two-thirds reduction in
childhood morbidity and mortality due to vaccine-preventable diseases by 2015.13 GIVS
has adopted a four-pronged strategy for achieving these goals that includes: (1) ensuring
protection of more people in a rapidly changing world; (2) introducing new vaccines and
technologies; (3) integrating immunization, other health interventions, and surveillance in
the health systems context; and (4) developing global partnerships to support and finance
immunization programs. 14 Ensuring success of these programs will benefit not only the
health of individuals but also the economies of developing countries. 5 Overall, the com-
bination of successful immunization programs and effective response mechanisms to dis-
ease outbreaks and public health emergencies will benefit all countries in this increasingly
interdependent world.
III. HIV/AIDS
June 2006 marked twenty-five years since the first AIDS case was reported.' 6 Many
advances have been made in that time, but, as highlighted by the events of 2006, universal
access to care and treatment remains an ambitious goal. The number of people living with
FIV/AIDS increased in 2006, and currently there are an estimated 39.5 million people
living with HIV/AIDS globally.17 Of this number, approximately two million are children
under fifteen years of age.' 8 Additionally, there were over four million new HIV infec-
tions and almost three million deaths due to AIDS in 2006.19 Approximately half a mil-
lion of these new infections and over 300,000 of these deaths occurred in children under
fifteen. 20
While these numbers demonstrate that there is much progress yet to be made, there
have been many positive steps forward. Expanded access to antiretroviral treatment is
estimated to have resulted in a gain of approximately two million life years in low and
12. See, e.g., Press Release, Pan American Health Organization (PAHO), Health Ministers Approve Rubella
Elimination, Increased Vaccination Coverage (Sept. 28, 2006), available at http://www.paho.org/English/DD/
PIN/pr060929.htm (noting an agreement by health ministers on a new regional strategy to sustain immuniza-
tion programs in the Americas); PATH, Cambodia Achieves Significant Boost in Immunization, Oct. 16,
2006, available at http://www.who.int/immunization/newsroom/PRCambodia-16-10_2006.pdf (reporting a
dramatic increase in immunizations in Cambodia as a result of a collaborative effort between the government,
international organizations, and other entities).
13. WHO & UNICEF, GLOBAL IMMUNIZATION VISION AND STRATEGY 2006-2015 8 (2005), available at
http://www.who.int/vaccines-documents/DocsPDFO5/GVSFinal-EN.pdf.
14. Id. at 7, 12-13
15. See Bloom, supra note 10, at 37 (reporting research that finds that "immunization does appear to be an
important tool for improving survival and strengthening economies").
16. See Kaiser Family Foundation, The Global HIV/AIDS Timeline, available at http://www.kff.org/
hivaids/timeline/hivtimeline.cfm (last visited Feb. 15, 2007).
17. See UNAIDS, UNAIDS/WHO AIDS EPIDEMIC UPDATE: DECEMBER 2006 (2006), available at http://
www.unaids.org/en/IHVdata/epi2006/default.asp (follow "Global Summary of the AIDS Epidemic"
hyperlink).
18. See id. (follow "Global Summary of the AIDS Epidemic" hyperlink).
19. See id. (follow "Maps" hyperlink).
20. See id. (follow "Global Summary of the AIDS Epidemic" hyperlink).
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middle income countries since 2002.21 This progress supports the United Nations' en-
dorsed goal of universal access to HIV prevention, care, and treatment by 2010 but also
makes it clear that there is much to be accomplished in the next four years if this goal is to
be reached.22
One significant step toward this goal in the United States was the endorsement of new
recommendations by the Centers for Disease Control and Prevention, which support IIV
screening as part of routine medical care for persons age thirteen to sixty-four.2 3 These
recommendations met a mixed response with certain groups, including the American Civil
Liberties Union, expressing concern that routine testing might serve a discriminatory pur-
pose. 24 Others, however, supported the new recommendations as a positive step toward
decreasing stigma and increasing access to care and treatment. 25
The past year also welcomed a once-a-day AIDS medication that combines three al-
ready existing drugs into one and simplifies a vitally important treatment regimen. The
drug, Atripla, was approved by the U.S. Food and Drug Administration (FDA) in July
2006 and was the product of a cooperative effort between drug makers Gilead Sciences,
Inc. and Bristol-Myers Squibb Co.2 6 While introduction of this drug into the U.S. market
represents significant progress, it is hoped that the new drug will also simplify treatment
in resource-constrained settings. Toward this end, the FDA approved the drug for over-
seas patients receiving assistance through the President's Emergency Plan for AIDS Relief
(PEPFAR).27
The once-a-day AIDS drug to be used in the PEPFAR distribution chain will be manu-
factured by the Indian generic drug manufacturing company Aurobindo Pharma.28 This
collaboration between the U.S. government and the Indian generic pharmaceutical market
is not insignificant given concerns expressed over India's recent restructuring and
strengthening of its intellectual property protections and the pressure that the United
States has sometimes been thought to exert on developing markets to strengthen patent
protection, especially those associated with the production of generic pharmaceuticals. 29
Private organizations and public-private collaboratives continue to play a vital role in
IIV/AIDS fimding and access to treatment, as demonstrated by numerous efforts by
21. See id. (follow "Introduction" hyperlink).
22. See UNAIDS, SCALING UP ACCESS TO HIV PREVENTION, TREATMENT, CARE AND SUPPORT: THE
NEXT STEPS (2006), available at http://data.unaids.org/Publications (follow "Publications" hyperlink; then
"IRC-pubo7"; then "jc1247-univac-the next steps en.pdf").
23. CENTERS FOR DISEASE CONTROL AND PREVENTION, REVISED RECOMMENDATIONS FOR HIV TEST-
ING OF ADULTS, ADOLESCENTS, AND PREGNANT WOMEN IN HEALTH-CARE SETTINGS (2006), available at
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm.
24. See Press Release, Am. Civil Liberties Union, ACLU Says New CDC H1V Testing Reconsmendations
Raise Health and Civil Liberties Concerns (Sept. 21, 2006), available at http://www.aclu.org/hiv/testing/
26819prs2006092 1 .html.
25. See Donald G. McNeil, Jr., U.S. Urges H.I.V. Tests for Adults and Teenagers, N.Y. TIMES, Sept. 22, 2006,
at Al.
26. See Marc Kaufman, FDA Clears Once-a-Day AIDS Drug, WASH. POST, July 13, 2006, at Al.
27. See Donald G. McNeil, Jr., F.D.A. Approves New AIDS Pill to Treat People in Poor Countries, N.Y. TIMES,
July 6, 2006, at A7.
28. See id.
29. See Int'l Ctr. for Trade and Sustainable Dev., Indian Parliament Approves Controversial Patent Bill,
BRIDGES, available at http://www.ictsd.org/weekly/05-03-23/storyl.htm; Frederick M. Abbott, The H,7o
Medicines Decision: World Pharmaceutical Trade and the Protection of Public Health, 99 Am. J. INT'L L. 317 (2005).
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pharmaceutical companies, and non-governmental and other organizations, and high-
lighted by Warren Buffett's $31 billion gift to the Bill and Melinda Gates Foundation.30
Also, increasing focus is being given to the needs of women and children affected by HIV/
AIDS, as reflected by both the May 2006 report Saving Lives: Children's Right to HIV and
AIDS Treatment and efforts by the UNAIDS Global Coalition on Women and AIDS to
increase efforts regarding prevention, care, and treatment for women.
31
IV. Trade and Intellectual Property Law
The U.N. Commission on Intellectual Property Rights, Innovation, and Public Health,
which collects and analyzes data regarding intellectual property rights and public health,
released a major report in April 2006 detailing, among other things, ideas for how best to
introduce medicines into developing countries fairly and expeditiously.3 2 The report ac-
knowledges the importance of intellectual property rights in stimulating innovation in
developed countries but appears to question their value in developing nations.
33
For example, the report questions the practice of protecting data from clinical trials
after the term of a pharmaceutical patent has expired.34 The Commission points out that
this practice could lead to the unnecessary repetition of clinical trials to prove the safety
and efficacy of a generic when this information is already available as a result of earlier
clinical trials for a bio-equivalent drug in patented form. These unnecessary clinical trials
would likely delay access to appropriate pharmaceuticals for patients in developing coun-
tries because many patients may only be able to afford much-needed drugs in generic
form. 35
International intellectual property protection continues to be a focus of the United
States Trade Representative (USTR), and, in 2006, the USTR cited both Russia and
China for lax enforcement of intellectual property rights. 36 For its part, China seems
relatively unruffled by potential ramifications and, in response to a U.S. request for addi-
tional information regarding Chinese enforcement of intellectual property rights, pro-
vided the following statement: "China has noted that Article 63.3 of the TRIPs
30. See Donald G. McNeil, Jr. & Rick Lyman, Buffett's Billions Will Aid Fight Against Disease, N.Y. TIMES,
June 27, 2006; Nathaniel Lipkus, How to Understand Product Development: Public-Private Partnerships as Vehicles
for Innovation in Combating Neglected Disease, 10 MICH. ST. U. J. MED. & L. 385 (2006).
31. See THE GLOBAL MOVEMENT FOR CHILDREN, SAVING LIVES: CHILDREN'S RIGHT ro HIV AND
AIDS TREATMENT (2006) available at http://unicef.org/aids/files/Saving-Lives-English-final.pdf (comprised
of UNICEF, Oxfam, Plan International, Save the Children, World Vision, ENDA Tiers Monde and the
Latin American and Caribbean Network for Children); UNAIDS, Global Coalition on Women and AIDS,
available at http://www.unaids.org/en/MediaCentre/Newsletter/200601/060122-gcwa.asp (last visited Feb.
15, 2007); Sharon LaFraniere, Slowly, Africa Starts to Care for AIDS Children, N.Y. TIMES, Mar. 8, 2006,
available at http://www.nytimes.com/2006/03/08/international/africa/08lesotho.htm?pagewanted=l&ei=
5070&en=cOf1962634e79695&ex=l 164690000.
32. See WORLD HEALTH ORG., PUBLIC HEALTH INNOVATION AND INTELLECTUAL PROPERTY RIGHTS




35. See id. See also R. Levin, UN Commission on IP Issues Report, 25 BIOTECHNOLOGY L. REP. 296 (2006)
(providing a more detailed review of the Commission's Report).
36. See Christopher S. Rugaber, USTR Cites Russia, China for IPR Violations, but Avoids Punitive Action, 72
BNA PAT., TRADEMARK & COPYRIGHT J. 1768, 11 (2006).
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Agreement only refers to a member's right to request information, but there is no men-
tion of a corresponding obligation of the requested member to actually follow the re-
quest."37 China, however, demonstrated some concern for intellectual property
protection and, following an investigation of numerous web sites, shut down seventy-six
that were distributing pirated materials and ordered 137 others to modify the content of
their sites.3s Whether this concern for intellectual property rights will extend beyond
efforts to control distribution of pirated materials via the internet remains to be seen.
In addition to restructuring its intellectual property laws in 2005, India adopted new
changes in 2006 intended to increase innovation by simplifying the patent application
process. 39 Due to the number of recent changes to Indian patent law, it is unclear how
courts will construe the new laws and what impact this will have on investors or consum-
ers. For instance, two patients-rights groups brought suit against Gilead Sciences in an
Indian court in May 2006 in an attempt to stop Gilead from patenting a generic HIV/
AIDS pharmaceutical. 4° Subsequently, Gilead signed licensing agreements with several
pharmaceutical companies in India for the manufacture and distribution of the drug at
issue.41
There is continuing concern in some sectors around the issue of direct-to-consumer
importation of Canadian pharmaceuticals into the United States. A recent report by the
Fraser Institute found that the annual total value of cross-border internet sales from Ca-
nada into the United States is approximately CDN$507 million (approximately US$450
million) and that 47 percent of the value of these sales is accounted for by pharmaceuticals
not available in generic form in the United States.42 The report discussed this activity as a
likely violation of U.S. patent law, but it is unclear whether or to what extent prosecution
is being pursued in these cases.
The European Union and Council of Europe have also expressed concerns regarding
online pharmaceutical sales and counterfeit drug sales. 43 Although the line separating
public health concerns from financial and intellectual property concerns in the debate
over internet sales of drugs remains unclear, both the European Union and the Council of
Europe continue to investigate the issue and work toward a more comprehensive legal
solution. 44
37. See Christopher S. Rugaber, China Resists U.S. Request at WTO For More Information on IPR Enforcement,
71 BNA PAT., TRADEMARK & COPYRIGHTr J. 1755, 362 (2006).
38. See Kathleen E. McLaughlin, Government Shuts Down Web Sites in China That Distributed Pirated Mater-
ials, 71 BNA PAT., TRADEMARK & COPYRiGHTJ. 1758, 438 (2006).
39. See Vir Singh, India Modifies Patent Rules to Boost Innovation and Attract Investment, 72 BNA PAT.,
TRADEMARK & CopYIurrJ. 1771, 89 (2006).
40. See Amelia Gentleman & Hari Kumar, AIDS Groups in India Sue to Halt Patent for U.S. Drug, N.Y.
TsIMS, May 12, 2006, available at http'//www.nytnes.com/2006/05/12/world/asia/12aids.htl?ex=11646900
00&en=2ced8337100161cc&ei=5070.
41. Pharm. Bus. Review Online, Gilead Licenses Viread to Eight Generic Companies, Sept. 26, 2006,
available at http://www.pharmaceutical-business-review.com/artcle-news.asp?guid=E945AOFB-F9EF-46D3-
9C4F-64552E1766B1 &z=.
42. Brett J. Skinner, The Fraser Institute, Price Controls, Patents, and Cross-Border Internet Pharmacies: Risks
to Canada's Drug Supply and International Trading Relations, Feb. 2006, available at httpJ/www.fraserinstitute.
ca/admin/books/files/PriceControls&XborderPharmacies 1.pdf.
43. Arthur Rogers, Council of Europe Weighs Accord on Curbing Counterfeit Drugs, 71 BNA PAT., TRADEMARK
& COPYRIGHT J. 1766, 700 (2006).
44. See id.
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V. Stem Cell Research and Funding
Developments in stem cell research and funding at the international, regional, and na-
tional levels continued in 2006. While ethical and moral issues relating to the legality and
funding of embryonic stem cell research remained at the forefront of legislative and policy
debates, other pressing issues emerged.
A. INTERNATIONAL
Currently, no international laws regulate the funding and use of stem cells and embryos
in research; at the international level, countries have been able to agree on only the non-
binding United Nations Declaration on Human Cloning.45 Nor is there an international
consensus on proper regulatory restraints on stem cell research. At the end of 2005, this
lacuna in regulatory and ethical guidelines was exposed when an international scandal
broke forth over the revelation that a Korean scientist had fabricated stem cell experi-
ments and the Korean Health Ministry had bought eggs from women, including research-
ers in labs, for use in these experiments. 46 A host of ethical and regulatory questions,
including the development of informed consent principles, prevention of the commodifi-
cation of human genetic material, and legislative protection of women's reproductive
rights, became urgent.47
In response to this need for clear ethical standards, leading ethicists, scientists, and law-
yers from around the world met at the beginning of 2006 to form the Hinxton Group, an
international consortium on stem cell ethics and law. The group expressed concern that
conflicting national regulations discourage international research collaboration and leave
scientists unsure how to conduct themselves in an ethically responsible way. It, therefore,
issued recommendations for the creation of an international ethical code for stem cell
research and resolved to continue to develop guidelines as new ethical dilemmas
materialize. 48
B. REGIONAL
Only the European Union has cooperated at the regional level to fund stem cell re-
search. In 2006, the Council of the European Union agreed to continue funding human
embryonic stem cell research within the twenty-five member states. 49 These research
grants will come out of the European Union's six-year, $65 billion research budget.50 To
achieve broader consensus among member states, the new EU rules prohibit funding the
45. See U.N. Declaration on Human Cloning, U.N. Doc. A/Res/59/280 (Mar. 23, 2005). See also Press
Release, General Assembly Adopts United Nations Declaration on Human Cloning by Vote of 84-34-37
(Mar. 8, 2005), available at http://www.un.org/News/Press/docs/2005/ga0333.doc.htm.
46. S. Korea Cloning Pioneer Disgraced, BBC NEws, Nov. 24, 2005, available at http://news.bbc.co.uk/2/hi/
asia-pacific/4465552.stm.
47. See generally Ubaka Ogbogu, A Review of Pressing Ethical Issues Relevant to Stem Cell Transnational Re-
search, 14 HEAL-i L. REv. 39 (Mar. 22, 2006).
48. Conflicting Laws Hinder Research, BBC NEWS, Feb. 25, 2006, available at http://news.bbc.co.uk/2/hi/
science/nature/4748884.stm.
49. Associated Press, EU Will Fund Human Stem Cell Research Without Cloning, Killing Embryos, BOSTON
HERALD, Jul. 24, 2006.
50. Id.
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destruction of human embryos necessary for stem cell harvesting, which must be funded
from outside the EU budget.51 Similarly, the European Union will not fund research for
human cloning for reproductive purposes.
52
C. NATIONAL
National laws governing methods and funding of stem cell research vary widely world-
wide. To date, some fifty countries have passed laws or issued regulations against human
cloning. 53 Others, such as Iran and Singapore, have extremely liberal human embryonic
stem cell laws and generous funding of research.5 4 This year, for example, Singapore
began building a nationally-fimded stem cell bank and authorized the commercial produc-
tion and sale of human embryonic stem cell lines.55
Several countries moved to liberalize their laws within the last year. In November
2006, the Australian Senate voted to overturn the ban on developing embryonic stem cell
lines; the House of Representatives approved the bill in December 2006.56 New Zealand
similarly began considering relaxing laws on the use of human embryos for research but
has not yet proposed any legislationS7
The United States also attempted to revise its laws on stem cell funding. Although
there are no federal laws prohibiting stem cell research, federal funding has been re-
stricted to research on embryonic stem cell lines created before August 9, 2001, which
now number around twenty.S8 In July 2006, Congress passed a bill to remove this restric-
tion and provide federal funding to research on newly created stem cells.5 9 The bill failed,
however, when President Bush used the first veto of his presidency to defeat it, and Con-
gress subsequently failed to override his veto.60
In the past two years, more than 100 bills have been considered by dozens of state
legislatures. 61 Some, including California, Connecticut, Illinois, Maryland, and New
Jersey, have allocated state funds to research; South Dakota has banned it entirely; and
other states fall somewhere in between.62 In 2006, several U.S. states created programs to
fund stem cell research and attract scientific research, some of which were a direct reac-
tion to the President's veto. In 2006, the Maryland legislature created the Maryland Stem
Cell Research Fund, which will provide grants for adult and embryonic stem cell research.
California also announced the first grants under its funding program, which had been
51. Id.
52. Id.
53. Gregory M. Lamb, How Cloning Stacks Up, CHRISTIAN ScI. MONITOR, July 13, 2006, at 13.
54. Anne Barnard, Iran Looks to Science as Source of Pride, BOSTON GLOBE, Aug. 22, 2006, at Al.
55. Wayne Arnold, Science Haven in Singapore: Luring Top Stem Cell Researchers with Financing and Freedom,
N.Y. TIMES, Aug. 17, 2006, at Cl.
56. Michael Madigan, Cure-all for Cloning: Bill Wins Backing in Senate, COURIER MAIL (Aust.), Nov. 8,
2006, at 7; Australia Relaxes Stem Cell Restrictions, C-ICAGO TRIB., Dec. 7, 2006, at 12.
57. Matthew Torbit, Call for Embryo Freedom, DOMINION POST (N.Z.), Aug. 5, 2006, at 5.
58. Erin Cline, Questions & Answers/Stem Cell Research, L.A. TIMES, July 30, 2006, at A2.
59. Id.
60. Id.
61. Jodi Rudoren, Stem Cell Work Gets States' Aid after Bush Veto, N.Y. TIMES, July 25, 2006, at Al.
62. Nat'l Conference of State Legislatures, State Embryonic and Feral Research Laws, www.ncsl.org/pro-
grams/health/genetics/embfet.htm (last visited Feb. 17, 2007).
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approved by the state's voters in 2004 but delayed by legal challenges until 2006.63 Most
notably, in what some saw as a decisive victory for scientific progress, in November 2006,
Missouri voters approved an amendment to protect all stem cell research not prohibited
by federal law. 64
VI. Bioterrorism
In 2006, the potential dangers of the growing biotechnology industry, inadequacy of
current legal regimes, and necessity of robust lab safety standards were the prominent
issues in international and national efforts to counteract and prevent bioterrorism.
A. INTERNATIONAL
Since 2001, many nations, including the United States, India, China, and Cuba, have
pursued biochemical research using dangerous viruses and bacteria.65 Although advances
have been made (in 2006, for example, researchers created a vaccine against the deadly
ricin poison),66 this expansion of biological research increases the risk of harm caused by
intentional or accidental release of these lethal agents.
Since the SARS virus outbreak was traced to lax safety standards at three different labo-
ratories in Asia, the international community has worked to regulate and improve lab
safety. In 2005 and 2006, states implemented the WHO's new Laboratory Biosafety
Manual, 67 passing laws on the possession, import, transport, and disposal of biological
agents and toxins.68 In 2006, Interpol also launched a biocriminalization project to de-
velop model legislation for countries that lack established legal frameworks to prepare for
and respond to bioterrorism. 69 Interpol also issued a Bioterrorism Incident Pre-Planning
and Response Guide, which provides states with tools for prevention and response
efforts.70
Nonetheless, the global community has made little progress toward limiting and regu-
lating the proliferation of potentially dangerous biotechnology. Countries still disagree
over which pathogens should be regulated for export. 71 The existing international agree-
ments on bioterrorism, the 1972 Biological and Toxin Weapons Convention and 1993
Chemical Weapons Convention, are relatively weak and do not address current
problems. 72 Consequently, in May 2006, the Secretary General of the United Nations
63. Stem Cell Research Funding Generates Controversy, CLICAL TRIALS ADVISOR, Vol. 11, No. 11, June 1,
2006.
64. Rachel Melcer, Vote Clears Way for Research, ST. Louis POsT-DiSPATCH, Nov. 9, 2006, at C1.
65. Joby Warrick, The Secretive Fight Against Bioterror, WASH. POST, July 30, 2006, at Al.
66. Associated Press, Researchers Create Human Ricin Vaccine, N.Y. TIMES, Jan. 31, 2006, at Al 7.
67. WORLD HEALTH ORG., LABORATORY BIOSAFETrY MANUAL (3d ed. 2004), available at http://www.who.
intlcsr/resources/publications/biosafety/Biosafety7.pdf.
68. Chang Ai-Lien, WHO Praises Lab Safety Culture Here, STRAITS TIMES (Singapore), Mar. 10, 2006.
69. INTERPOL, Outcome Statement: Interpol Workshop on Preventing Bioterrorism, Nov. 6-8, 2006,
http://www.interpol.int/Public/BioTerrorism/Workshops/KievNov2006/OutcomeStatement.asp.
70. INTERPOL, Bioterrorism Incident Pre-Planning & Response Guide (2007), available at http://www.in-
terpol.int/Public/BioTerrorism/BioterrorismGuide.pdf.
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called for a global forum on biological terrorism to develop new international bioterror-
ism initiatives.73 Additionally, in November 2006, he urged the creation of international
safeguards to regulate the growing biotechnology industry and harmonize conflicting na-
tional rules. 74 This push should ensure that bioterrorism issues remain a key part of the
agenda in the international arena in the coming years.
B. NATIONAL: UNITED STATES
In June 2006, the United States began construction on a $128 million facility to house
the National Biodefense Analysis and Countermeasures Center (NBACC). The NBACC
raises concerns that the use of deadly germs in government tests might represent a viola-
tion of international treaties that prohibit production of even small amounts of biological
weapons. According to some critics, prioritizing the funding of NBACC and other bi-
oterrorism research acts to the detriment of other fields of research. Thus, in 2006, more
than 700 U.S. scientists wrote a letter expressing alarm that increased funding to research
on biochemical threats had caused public health research to suffer. 75
The U.S. Congress may consider these and other issues in 2007. In 2006, the U.S.
Senate had not yet reauthorized the bioterrorism-preparedness legislation passed in 2001
and therefore will consider the bill again in 2007. The Senate has proposed legislation
that would maintain the federal level of spending on public health preparedness, request
matching state funds, and expand the disease surveillance system. 76
VII. Violence, Health, and Human Rights
This year also bore witness to the growing recognition that a wide range of human
rights issues are, in fact, health issues. The issue of violence and its impact on the health
and well-being of individuals was one of the many important matters highlighted in 2006,
particularly with the completion of two major multi-year studies by the United Nations.
In July 2006, the U.N. Secretary General published an in-depth study on all forms of
violence against women. 77 The study provides a more detailed understanding of the
health, social, and economic costs of violence against women and emphasizes the impor-
tance of immediate and effective action to combat such violence. Later in the year, the
U.N. Secretary-General's Study on Violence Against Children was published. 78 It repre-
sents a three-year study on the impact of violence in the home, schools, community, work-
place, and juvenile justice settings on all children. 79 This seminal study highlights the
73. Reuters, U.N. Leader Urges Biotecb Safeguards, N.Y. TIMES, Nov. 19, 2006.
74. Id.
75. lain Hollingshead, Whatever Happened to... theAntbraxAttacks?, THE GUARDIAN (UK), Sept. 9, 2006,
at 36.
76. Renae Merle, Senate to Take Up Biological Threats: Firms Could Get Funding Sooner, WASh. Pos-r, Nov.
15, 2006, at D1.
77. The Secretary General, In-Depth Study on All Forms of Violence Against Women, U.N. Doc. A/61/122/
Add.I (July 6, 2006), available at http://daccessdds.un.org/doc/UNDOCIGEN/NO641974.pdfOpen
Element.
78. The Secretary General, Promotion and Protection of the Rights ofChildren, U.N. Doc. A/61/299 (Aug. 29,
2006), available at http-//www.violencestudy.org/IMG/pdf/English.pdf.
79. Id.
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dramatic and often unseen effects of violence on children's health and well-being. The
U.N. General Assembly also adopted a resolution supporting the Study on Violence
Against Children and calling upon all countries to implement the Study's recommenda-
tions and put an end to abusive treatment of children.80 These two key studies and their
recommendations provide a better understanding of the risks that women and children
face and compel government action.
Additional initiatives were launched in late 2006 to address issues of violence. For ex-
ample, the Pan American Health Organization (PAHO) launched a new public awareness
campaign to help prevent violence against women, a widespread problem in the Americas
as in other regions8I In addition, noting the growing evidence of linkages between vio-
lence and HIV, the Global AIDS Alliance started a new program to combat violence
against women and children s2 Research shows that 20 percent of girls and 10 percent of
boys experience sexual abuse as children and that refugees and displaced persons, 80 per-
cent of whom are women and children, also experience increased sexual or physical vio-
lence.8 3 All of these individuals are at greater risk of HIV infection, as well as a range of
other health problems.
The U.N. studies and other initiatives mentioned above represent important steps in
understanding the incidence and effects of violence and in developing effective programs
to reduce, and ultimately eliminate, such violence. Further action is required at all levels
to combat violence and to ensure the health and human rights of all individuals.
VIII. Obesity
In the past decade, the incidence of obesity worldwide has increased dramatically. To-
day, at least 400 million adults are obese.84 The world's 1.6 billion overweight people now
outnumber the 800 million hungry, and the WHO projects that by 2015, 2.3 billion adults
will be overweight and 700 million will be obese.85 Although obesity is more prevalent in
the developed world, it now constitutes a global epidemic, affecting every region with the
exception of sub-Saharan Africa.86 In China alone, sixty million people are obese.8 7
Overweight and obesity both result in chronic diseases, such as cardiovascular conditions,
diabetes, and respiratory diseases, which account for 46 percent of the global disease bur-
80. Rights of the Child, U.N. GAOR, 61st Sess., U.N. Doc. A/C.3/61/L.16/Rev/1, 1 13-19, (Nov. 17,
2006).
81. Press Release, Pan American Health Org., PAHO Calls for End to Violence Against Women (Nov. 21,
2006), available at http://www.paho.org/English/DD/PIN/pr061121.htn.
82. GLOBAL AIDS ALLIANCE, ZERO TOLERANCE: STOP THE VIOLENCE AGAINST WOMEN AND CHIL-
DREN 3 (2006), available at http://www.globalaidsalliance.org/GAAViolenceAgainstWomenAdvocacy_
Brief.cfm.
83. Id.
84. World Health Org., Obesity and Overweight, Sept. 2006, http://www.who.int/mediacentre/factsheets/
fs31 I/en/index.html.
85. Id.
86. WORLD HEALTH ORG., EUROPEAN MINISTERIAL CONFERENCE ON COUNTERACTING OBESny:
DIET AND P-IYsIcAL AcTIVITY FOR HEALTH, THE CHALLFNGE OF OBESrTY IN THE WHO EUROPEAN
REGION AND THE STRATEGIES FOR REsPONSE 51, Doc. No. EUR/06/5062700/6 (Aug. 28, 2006), available at
http://www.euro.who.int/Document/NUT/Instanbul-conf-edoc06.pdf [hereinafter WHO CHALLENGE].
87. Agence France-Presse, Number of Obese Chinese Swells to 60 Million, LIFESTYLE NEWS, Nov. 6, 2006,
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den.88 Morbidity and mortality associated with increased weight problems inflict huge
burdens and costs on families and health systems.89 Despite this evidence, governments
and international agencies still have much work to do to address the problem. 90 A multi-
sectoral response is required to address factors that contribute to high-fat diets and seden-
tary lifestyles and to treat obesity and disease and reduce their impact.91
A. INTERNATIONAL
Although obesity received significant attention as a newly emerging issue in 2006, the
WHO, in fact, began sounding the alarm in the 1990s on the problems of overweight and
obesity through expert consultations and public awareness campaigns. 92 Thanks to the
WHO's support, several international policy instruments have been adopted since that
time. In 2004, the World Health Assembly adopted the WHO Global Strategy on Diet,
Physical Activity, and Health. 93 This population-wide, prevention-oriented strategy calls
for action at the international, regional, and national levels and seeks to address the risk
factors for obesity and chronic disease, unhealthy diet, and physical inactivity. The Codex
Alimentarius Commission, the standard-setting body for food of the WHO and U.N.
Food and Agriculture Organization, also is working to support the global strategy through
food labeling and identification of healthy foods.94 Moreover, in October 2005, the
WHO proposed a global goal of a 2 percent reduction in chronic disease death rates each
year for a decade. 95
In 2006, the International Congress on Obesity, a private organization of obesity ex-
perts, also met to outline draft standards to protect children from exploitative techniques
for the marketing of junk food.96 They called upon the United Nations and governments
to use the principles to develop globally enforceable standards to protect children and
reduce the incidence of overweight and obesity among the very young.
97
B. REGIONAL
Significant progress toward the adoption of measures to address overweight and obesity
has been made at the regional level. The European region has made the most progress in
88. Global Strategy on Diet, Physical Activity and Health, WHA Res. 57.17, World Health Assembly, 57th
Assembly (May 22, 2004), available at http://www.who.int/gb/ebwha/pdf files/"HA57/A57-R17-en.pdf
[hereinafter Global Strategy].
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90. World Health Org., Nutrition, Controlling the Global Obesity Epidemic, available at http://www.who.
int/nutrition/topics/obesity/en/index.html [hereinafter WHO, Controlling].
91. WHO, Regional, supra note 89.
92. WHO, Controlling, supra note 90.
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94. WHO CHALLENGE, supra note 86, at 52.
95. World Health Org., Regional Office for the Western Pacific, Noncommunicable Disease Prevention
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pdf [hereinafter WHO, Disease Prevention and Control].
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developing and implementing a region-wide strategy to reduce overweight and obesity.
Within the European region, more than one million deaths annually are caused by disease
related to excess body weight.9s The prevalence of obesity has risen three-fold in the last
two decades, and one-half of adults and one-fifth of children are now overweight. 99 In the
past few years, the European Union has adopted several regional instruments to counter-
act the problem. Since 2005, the EU Platform on Diet, Physical Activity, and Health,
which will be reviewed in 2007, has provided a series of workshops for commercial, pro-
fessional, and consumer organizations with a stake in the issues. 00 In September 2006,
the WHO Regional Committee for Europe approved the European Strategy for the Pre-
vention and Control of Noncommunicable Diseases, a comprehensive program that
targets individuals at high risk, maximizes effective treatments, and strengthens national
health systems to improve prevention and control.'(n
Most importantly, on November 16, 2006, European health ministers from fifty-three
countries approved the first charter to fight obesity.102 Drafted by the WHO in consulta-
tion with European countries, the European Charter on Counteracting Obesity aims to
curb the obesity epidemic within five years and reverse the trend by 2015.103 It also plans
to harmonize the marked policy differences in the marketing of food to children across
Europe as a possible precursor to the adoption of an international code of practice. 104
While the European Union has made more progress than other regions on obesity, it is
not alone in responding to this public health concern. In 2004, for example, the Pan-
American Health Organization adopted a Protocol for the Nutritional Management of
Obesity, Diabetes, and Hypertension for the Caribbean.10 5 The Protocol sets forth
guidelines for standardizing nutritional care and managing overweight-related disease that
are the main causes of disability, illness, and death in the region. 10 6 The Western Pacific
Region has also worked to stem the chronic noncommunicable diseases within that region.
On the basis of the 2005 WHO proposal to prevent and control such diseases, the West-
ern Pacific Regional Committee endorsed a framework of action focused on national plan-
ning, surveillance with periodic national surveys, health promotion, and clinical
prevention accessible by all members of society. 10 7
C. NATIONAL: UNITED STATES
In the United States, obesity and overweight have reached record levels. Today, nearly
two-thirds of adult Americans are either overweight or obese, and the rates only continue
98. WORLD HEAsiFui ORG., EUROPEAN MINISTERIAL CONFERENCE ON COUNiFERACTING OSFSF:
Dim- AND PiYsicAL AcTvIITy FOR HiEALI I, EUROPEAN CHARTER ON COUNTERACTING OBESI'IW 1, Doc.
No. EUR/06/5062700/8, (Nov. 16, 2006), available at http://www.euro.who.int/DocumentIE89567.pdf.
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to rise.' 08 From 1980 to 2004, childhood overweight rates more than tripled, up from 5
percent to 17 percent. 0 9
In the past few years, the vast majority of states have considered bills to combat obesity
by, among other things, improving school nutrition, banning certain foods from schools,
and limiting the use of unhealthy fats in restaurants."10 Civil lawsuits have also been filed
by several individuals against food companies."' Most famously, parents of minors
brought suit against McDonald's alleging state consumer protection law violations for
representing its food as substantially more healthy than it is.112 Litigation against Mc-
Donald's and other food chains has prompted federal and state legislation to ban certain
lawsuits against food companies or make them more difficult. Eighteen states have
banned personal injury suits against the food industry and, in the past few years, the U.S.
Congress has also introduced bills to prevent individuals from claiming fast food restau-
rants made them fat."l 3
The emergence of obesity issues as a prominent public health concern reflects the trend
of an ever increasing number of health issues that require the attention of governments,
international organizations, and the general public.
IX. Conclusion
There is growing acknowledgement at all levels of government and in the private and
nonprofit sectors of the importance and far-reaching impact of health issues. As the
W-HO has stated:
Health is increasingly seen as a key aspect of human security. Actual or potential
health emergencies are objects of intense public attention and debate. Violence con-
tributes significantly to preventable morbidity and mortality. Diseases linked to pov-
erty accelerate societal breakdown. Wider concerns about security include the
dependence of health on safe food and water, financial security, and protection from
the effects of climate change .... Countries, at all levels of development, are realizing
the need for sustained, equitable increases in health investment for them to become
or remain stable and prosperous nations. 1 4
All sectors of society are affected, and thus all fields of the legal profession are impli-
cated. Ultimately, a comprehensive, multi-sector approach to international health law is-
sues is the best way of ensuring health and security for all.
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